Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Kai Duan and Zejun Wang.
Kai Duan
Connection Strength
0.741
Zejun Wang
  1. Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models. Emerg Microbes Infect. 2020 Dec; 9(1):2606-2618.
    View in: PubMed
    Score: 0.229
  2. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020 04 28; 117(17):9490-9496.
    View in: PubMed
    Score: 0.219
  3. Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan. Nat Commun. 2021 Aug 05; 12(1):4846.
    View in: PubMed
    Score: 0.060
  4. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial. EClinicalMedicine. 2021 Aug; 38:101010.
    View in: PubMed
    Score: 0.060
  5. Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan. Nat Commun. 2021 07 06; 12(1):4144.
    View in: PubMed
    Score: 0.060
  6. Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate. Emerg Microbes Infect. 2020 Dec; 9(1):2653-2662.
    View in: PubMed
    Score: 0.057
  7. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. JAMA. 2020 09 08; 324(10):951-960.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.